MMMaria Mierniczek

Maria Mierniczek

*This is an algorithmically generated author record based on publicly available information.

Maria Mierniczek has a total of 23 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    The Role of physical activity and nutrition in managing pain, fatigue, and inflammation in endometriosis

    by Dominika Dmowska, Paweł Zdebski, Karolina Rymska, Ewa Gloc, Rafał Ejsner, Marcelina Kaczmarek, Mateusz Mierniczek, Maria Mierniczek, Daniel Załęski, Mikołaj Lewandowski, et al.

    Endometriosis is a highly prevalent inflammatory disease that affects millions of women. Endometriosis affects between 10-15% of women of reproductive age globally what is representing nearly 180 million cases worldwide. In Poland alone, the number of sufferers reaches 3 million. Its diagnosed much more frequently among women seeking treatment for fertility problems. That’s estimated more than half of them may have a sign of endometriosis. Currently used medications only reduces the symptoms of the disease, which is why the interdisciplinary aspect in the context of endometriosis is so important, as is the attempt to alleviate the course of the disease through alternative methods like balanced diet and physical activity. In this study, we focused on examining the impact of physical activity on the course of endometriosis. Materials and methods: The review was conducted using publications published in the PubMed, Google Scoolar and UpToDate. Our search included the following keywords: pain, endometriosis, quality of life, fatigue, fertility, physical activity. We based on literature published between 2008-2025. Results: According to the survey and literary reports physical activity significantly improves the quality of life of patients affected by endometriosis. Physical activity significantly improves the quality of life of patients with endometriosis. This positive impact is felt both physically and mentally, which is often disturbed by this condition.

  • Open Access

    High-Intensity vs. Low-Intensity Exercise in the Management of Irritable Bowel Syndrome

    by Paweł Zdebski, Dominika Dmowska, Mateusz Mierniczek, Maria Mierniczek, Aleksandra Bilińska, Ewa Gloc, Daniel Załęski, Karolina Rymska, Mikołaj Lewandowski, Maciej Krzesimir Kuświk

    Background. Irritable bowel syndrome (IBS) is a prevalent functional gastrointestinal disorder characterized by chronic abdominal pain, altered bowel habits, and significant impairment in quality of life. Exercise has emerged as an effective non-pharmacological intervention for reducing IBS symptoms. Aim. This review aims to explore the current evidence on the effects of different exercise intensities: low- to moderate-intensity and high-intensity on symptomatic aspects of IBS. Material and Methods. A review of relevant literature was conducted using sources retrieved from PubMed and Google Scholar. Results. Regular low- and moderate-intensity exercise consistently helps reduce symptoms, improve quality of life, and support psychological well-being, with minimal risk of side effects. Higher-intensity workouts, including high-intensity interval training (HIIT), show more mixed results. When performed with appropriate frequency, intensity and recovery, they can enhance mental health and reduce systemic inflammation; however, they may also trigger temporary gastrointestinal discomfort in some individuals. Current evidence suggests that different exercise intensities can influence gut motility, the gut-brain axis and even the composition of the gut microbiome in distinct ways. Conclusion. Current evidence supports low- to moderate-intensity exercise as the most effective and safe strategy for managing IBS. High-intensity exercise may introduce additional long-term systemic benefits when introduced progressively and monitored carefully, but its effects on gastrointestinal symptoms remain inconsistent and require further study.


  • Open Access

    LOW-GRADE INFLAMMATION IN MODERN CIVILIZATION DISEASES: A NARRATIVE REVIEW OF MECHANISMS, BIOMARKERS, AND CLINICAL IMPLICATIONS

    by Mateusz Mierniczek, Maria Mierniczek, Ewa Gloc, Dominika Dmowska, Paweł Zdebski, Aleksandra Bilińska, Kinga Kaczmarska, Kinga Rosołowska, Jarosław Dudek, Aleksandra Mierniczek

    Over the last century, the epidemiological landscape has shifted from acute infectious diseases to chronic non-communicable diseases (NCDs), including cardiovascular disease, type 2 diabetes, and neurodegeneration. These pathologies share a common, underlying biological substrate: chronic, low-grade inflammation, which is hypothesized to arise from an evolutionary mismatch between the human genome and the modern anthropogenic environment. This narrative review synthesizes evidence regarding the molecular mechanisms of sterile inflammation, emerging biomarkers, and therapeutic interventions by integrating data from immunology, metabolic medicine, and large-scale clinical trials. The analysis demonstrates that the pathology is driven by triggers such as metabolic surplus and oxidative stress, which activate the NLRP3 inflammasome and NF-κB pathways. This activation leads to reciprocal dysfunction between insulin signaling and endothelial integrity, creating a metabolic-vascular nexus that drives atherosclerosis, while gut dysbiosis and blood-brain barrier disruption extend this inflammation to the central nervous system, promoting neurodegeneration. While high-sensitivity CRP remains the standard biomarker, emerging markers like suPAR and GlycA offer superior stability and prognostic value. Therapeutically, the CANTOS and LoDoCo2 trials have validated the efficacy of targeting specific inflammatory pathways (IL-1β, NLRP3) over broad immunosuppression. Ultimately, low-grade inflammation is identified as the defining physiological signature of the modern age, serving as the "common soil" for multimorbidity. Effective management necessitates the adoption of a Personalized Immunometabolism framework, integrating biomarker-guided pharmacotherapy (e.g., colchicine) with lifestyle interventions that resolve the fundamental evolutionary mismatch, as future progress depends on bridging the gap between prognostic biomarkers and actionable clinical protocols.

  • Open Access

    WEARABLE HEALTH TECHNOLOGIES IN CHRONIC DISEASE MANAGEMENT: CURRENT APPLICATIONS, BARRIERS, AND FUTURE PERSPECTIVES

    by Mateusz Mierniczek, Maria Mierniczek, Aleksandra Mierniczek, Kinga Kaczmarska, Kinga Rosołowska, Jarosław Dudek

    Wearable technologies are driving a paradigm shift in chronic disease management from clinics to patients 'everyday environments. Their applications are diverse: early arrhythmia detection in cardiology, optimal glycemic control in diabetology, remote monitoring in pulmonology, and opening new paradigms for objective assessment in neurology and medication adherence. This constant stream of data drives proactive, personalized & data-driven healthcare. Many of those advances are still limiting widespread clinical integration. Technical challenges regarding data validation and algorithmic transparency remain, alongside complex ethical questions about data privacy and the risk of algorithmic bias. Also, unresolved economic issues like reimbursement models threaten to increase health inequalities The future of digital health will depend on integrating wearable data with artificial intelligence. It will unlock predictive analytics to forecast disease exacerbations and enable the development of reliable digital biomarkers within the vision of P4 medicine - predictive, preventive, personalized, and participatory. This narrative review critically summarizes the available data, identifies these ethical and practical obstacles, and suggests ways to safely, successfully, and fairly incorporate wearable technology into standard medical procedures.

  • Open Access

    Move to sleep: how exercise timing and intensity shape sleep quality - a narrative review

    by Mateusz Mierniczek, Wiktoria Mika, Maria Mierniczek, Kordian Kotte, Ewa Gloc, Dominika Dmowska, Aleksandra Bilińska, Paweł Zdebski, Aleksandra Mierniczek

    Background: Sleep and physical exercise represent two fundamental pillars of human health. The relationship between movement and sleep becomes particularly interesting when we consider how timing and intensity work together. While each factor independently affects sleep, their combined influence is increasingly recognized as crucial for understanding how physical activity impacts our nightly rest. Aim: To summarize current evidence on how different times of day and exercise intensities affect sleep quality, latency, and duration in healthy adult populations. Material and Methods: A narrative review was conducted using 32 peer-reviewed articles published in English. Sources were identified from PubMed, Web of Science, Google Scholar, and ScienceDirect. Inclusion criteria focused on healthy adult participants. Results: Exercise in the morning and afternoon was generally related to better sleep, but vigorous activity performed close to nighttime had mixed or bad effects. Moderate-intensity physical activity, especially when done over a long period of time, always made sleep better and made it take longer to fall asleep. Age, chronotype, and fitness level were some of the individual factors that changed the effects that were seen. However, differences in methods between studies, especially in how they measured sleep and how they did exercises, make it hard to compare them directly. Conclusions: Timing and intensity are critical modifiers of the sleep benefits of exercise. While moderate, earlier-in-the-day exercise appears most beneficial, tailored interventions based on individual characteristics may enhance sleep optimization strategies. Future research should prioritize standardized protocols and consider individualized approaches to optimize exercise timing and intensity for sleep health.


  • Open Access

    Digital Health Interventions for School-Aged Children: Effectiveness, Implementation, and Impact on 24-Hour Movement and Psychosocial Well-Being

    by Mateusz Mierniczek, Maria Mierniczek, Aleksandra Mierniczek, Kinga Kaczmarska, Kinga Rosołowska, Jarosław Dudek

    Introduction: Insufficient physical activity and prolonged sedentary behavior among school-aged children pose significant public health challenges. Historically, digital screens were viewed as drivers of this "sedentary pandemic," but post-2020 trends have repurposed digital tools, mobile apps, wearables, and exergames, as vectors for health promotion. This review synthesizes evidence on the effectiveness and theoretical mechanisms of these interventions, analyzing their impact on the 24-hour movement paradigm. Material and Methods: A narrative review was conducted focusing on studies published between 2013 and 2025. Relevant literature was identified through PubMed, Web of Science, and Scopus. Interventions were categorized by technology type, setting (school vs. home), and outcomes, including physical activity (PA), sedentary time, sleep, and psychosocial well-being. Results: Findings reveal a dichotomy between improved physical fitness and habitual behavior change. While apps improve metrics like agility, their impact on daily habitual activity is inconsistent. However, digital tools significantly reduced sedentary time (Mean Difference -33.12 min/day) and extended sleep (+17 min/night). Structural school-based programs, such as the "Super Quinas" project, outperformed standalone home interventions, achieving significant gains in MVPA (+18 min/day). Effectiveness relied on Behavior Change Techniques, though the "novelty effect" often limited engagement to 4–8 weeks. Conclusions: Digital health interventions offer promising opportunities to enhance pediatric well-being, particularly when embedded in "phygital" educational settings. Future research must address the "digital divide" and focus on strategies to sustain intrinsic motivation beyond the initial novelty phase.


  • Open Access

    Cardiotoxicity in cancer immunotherapy: from pathogenesis to prevention ? narrative review

    by Mateusz Mierniczek, Daniel Narożniak, Maria Mierniczek, Wiktoria Mika, Anna Rodzeń, Jan Wojdal, Katarzyna Ciepłucha, Aleksandra Wądołowska, Barbara Przybył

    Cancer immunotherapies, such as immune checkpoint inhibitors and chimeric antigen receptor T-cell therapy, improve survival but carry a risk of severe cardiotoxicity. Myocarditis is the most dangerous complication with high mortality, and its mechanism involves T-cell auto-aggression or cytokine storms. Risk management requires vigilance, monitoring of cardiac biomarkers, and imaging studies. Prompt treatment with high-dose glucocorticosteroids is crucial. Collaboration within cardio-oncology teams is fundamental for safety, and further research must focus on precise risk stratification to protect patients while maintaining therapeutic efficacy.